CAS 144143-96-4
:2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1)
Description:
2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1) is a complex organic compound characterized by its unique structural features, including a thiophene ring and an imidazole moiety. This compound exhibits both acidic and basic properties due to the presence of carboxylic acid and imidazole functionalities, which can participate in various chemical reactions, including proton transfer and coordination with metal ions. The methanesulfonate group enhances its solubility in polar solvents, making it suitable for various applications in organic synthesis and medicinal chemistry. Additionally, the presence of the butyl and phenyl groups contributes to its hydrophobic characteristics, influencing its biological activity and interaction with cellular targets. The compound's stereochemistry, indicated by the (αE) designation, suggests specific spatial arrangements that may affect its reactivity and binding properties. Overall, this substance is of interest in pharmaceutical research, particularly for its potential therapeutic applications.
Formula:C23H24N2O4S·CH4O3S
InChI:InChI=1S/C23H24N2O4S.CH4O3S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27;1-5(2,3)4/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29);1H3,(H,2,3,4)/b18-12+;
InChI key:InChIKey=DJSLTDBPKHORNY-XMMWENQYSA-N
SMILES:C(N1C(/C=C(\CC2=CC=CS2)/C(O)=O)=CN=C1CCCC)C3=CC=C(C(O)=O)C=C3.S(C)(=O)(=O)O
Synonyms:- 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (E)-, monomethanesulfonate
- 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1)
- 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, monomethanesulfonate
- 4-({2-butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate
- 4-[[2-Butyl-5-(2-Carboxy-3-Thiophen-2-Yl-Prop-1-Enyl)-Imidazol-1-Yl]Methyl]Benzoic Acid Mesylate
- Eprosartan Methanesulfonate
- Skf 108566J
- Eprosartan mesylate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Eprosartan Mesylate
CAS:Formula:C23H24N2O4S·CH4O3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:520.62Eprosartan Mesylate ((E)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid, monomethanesulfonate)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C23H24N2O4S·CH4O3SColor and Shape:White Crystalline PowderMolecular weight:424.145684-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; methanesulfonic acid
CAS:Formula:C24H28N2O7S2Purity:99%Color and Shape:SolidMolecular weight:520.6183Eprosartan Mesylate
CAS:Formula:C23H24N2O4S·CH4O3SColor and Shape:White To Off-White SolidMolecular weight:424.52 96.11Eprosartan mesylate
CAS:Controlled ProductFormula:C23H24N2O4S·CH4O3SColor and Shape:NeatMolecular weight:520.62Eprosartan Mesilate
CAS:Controlled ProductFormula:C23H24N2O4S·CH4O3SColor and Shape:NeatMolecular weight:520.62Eprosartan Mesylate
CAS:<p>Eprosartan Mesylate (SKF-108566J) is a competitive and reversible Angiotensin II Receptor Blocker.</p>Formula:C23H24N2O4S·CH4O3SPurity:99.72% - 99.93%Color and Shape:A White To Off- White PowderMolecular weight:520.62Eprosartan Mesylate
CAS:Controlled Product<p>Applications Eprosartan Mesylate is an angiotensin II receptor antagonists. Eprosartan Mesylate is used as an antihypertensive agent.<br>References Sheng, J. et al.: J. Pharmac. Sci., 88., 1021 (1999); Punzi, H.A. et al.: J. Hum. Hypertens., 18, 655 (2004);<br></p>Formula:C23H24N2O4S·CH4O3SColor and Shape:NeatMolecular weight:520.62Eprosartan mesylate
CAS:<p>Eprosartan mesylate is an angiotensin II receptor antagonist and a prodrug of eprosartan. It is used in the treatment of hypertension, congestive heart failure, and for the prophylaxis of organ rejection in renal transplantation. This drug has been shown to inhibit the activation of nuclear factor-κB (NF-κB) and the production of inflammatory cytokines such as growth factor-β1 (GF-β1). Eprosartan mesylate has also been shown to have a beneficial effect on experimental models of type 2 diabetes and metabolic disorders. In clinical trials, it was found that losartan had similar effects on lowering blood pressure as eprosartan mesylate, but the combination increased blood pressure more than either agent alone. Eprosartan mesylate should not be taken with drugs that are metabolized by cytochrome P450 enzymes because they may lead to serious adverse effects such</p>Formula:C23H24N2O4S•CH4O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:520.62 g/mol












